EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status

Sara Nofal iD, Edwin J Ostrin iD, Jianjun Zhang, Jia Wu, Paul Scheet, Mara B Antonoff, John V Heymach, Iakovos Toumazis iD

International Journal of Cancer · 2025-09 · 157 (5) · 941-953

DOI: 10.1002/ijc.35452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 18.04.2025. Verfasst von Sara Nofal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Neoplasms, Second Primary, Lung Neoplasms, Cancer Survivors, Early Detection of Cancer. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, The generous philanthropic contributions to The University of Texas MD Anderson Cancer Center Lung Moon Shot, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Personal history of cancer is an independent risk factor for developing lung cancer. However, it is not considered in the current US lung cancer screening (LCS) guidelines. In this study, we assessed the risk of developing lung cancer among cancer survivors across 24 different sites of first primary cancer stratified by their LCS eligibility status. Using data from the Patient History Database at the University of Texas MD Anderson Cancer Center, we calculated and compared the cumulative incidence of second primary lung cancer, the overall and the LCS eligibility status‐specific, stratified by the site of first primary cancer among cancer survivors. We found that among lung, head and neck (H&N), bladder, cervical, breast, and prostate cancer survivors, the risks of second primary lung cancer were statistically significantly higher compared to the overall risk among all cancer survivors (i.e., all cancer sites combined). Risk ratios (RR) ranged between 1.14 (95%CI:1.00–1.28, p = 0.0431) among prostate cancer survivors to 2.9 (95%CI:2.58–3.26, p < 0.001) among H&N cancer survivors. Other than first primary lung cancer (RR: 1.33; 95%CI:1.14–1.57; p < 0.001), H&N (RR: 1.73; 95%CI:1.45–2.05; p < 0.001) and bladder (RR: 1.32; 95%CI:1–1.74; p = 0.0483) cancer survivors, who were non‐eligible for LCS, had significantly higher lung cancer risk than all cancer survivors. In conclusion, H&N, bladder, cervical, breast, and prostate cancer survivors have a high risk of developing second primary lung cancer. Specifically, personal history of H&N and bladder cancer, even among non‐eligible for LCS individuals, remain at a sufficiently high risk, which warrants further consideration as an independent eligibility factor for LCS guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Second PrimaryLung NeoplasmsCancer SurvivorsEarly Detection of CancerHumansMaleFemaleMiddle AgedAgedRisk FactorsIncidenceAdult

Stichwörter der Autor:innen

cancer survivorslung cancerlung cancer screening guidelinespersonal history of cancerrisk factors

Autor:innen und Institutionen

  • Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Sara Nofal, Edwin J Ostrin, Iakovos Toumazis

Förderung

  • NCI NIH HHS
  • The generous philanthropic contributions to The University of Texas MD Anderson Cancer Center Lung Moon Shot
  • National Cancer Institute

Zitieren

APA

Nofal, S., J Ostrin, E., Zhang, J., Wu, J., Scheet, P., Antonoff, M. B., V Heymach, J., & Toumazis, I. (2025). Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status. International Journal of Cancer, 157(5), 941-953. https://doi.org/10.1002/ijc.35452

Vancouver

Nofal S, J Ostrin E, Zhang J, Wu J, Scheet P, Antonoff MB, et al. Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status. International Journal of Cancer. 2025;157(5):941-953. doi:10.1002/ijc.35452

BibTeX
@article{Nofal2025,
  author = {Nofal, Sara and J Ostrin, Edwin and Zhang, Jianjun and Wu, Jia and Scheet, Paul and Antonoff, Mara B and V Heymach, John and Toumazis, Iakovos},
  title = {Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status},
  journal = {International Journal of Cancer},
  year = {2025},
  volume = {157},
  number = {5},
  pages = {941--953},
  doi = {10.1002/ijc.35452}
}
Kostenlos starten →